New CDC Study Estimates 204,295 Americans Have Lupus News Update January 29, 2021 According to a new analysis funded by the Centers for Disease Control and Prevention, about 204,295 Americans...
Lupus Research Alliance Hails Approval of Aurinia’s Lupkynis(TM) (voclosoporin) Press Release January 23, 2021 First Oral Treatment for Lupus Nephritis; Second Lupus Treatment to Receive FDA Approval in Past Month NEW YORK, NY. January...
Update from LRA’s President on COVID-19 Vaccines in Lupus News Update January 14, 2020 Dear Friends, Happy New Year! On behalf of all of us at the Lupus Research Alliance (LRA), thank...
Vaccines and Lupus: What to Know Amid COVID-19 News Update January 13, 2021 January 14, 2021 LRA's President and CEO Kenneth Farber taped this video series - Vaccines and Lupus: What to Know...
Lupus Advocacy Delivers Again! News Update December 28, 2020 After much back and forth, last week the U.S. Congress passed the year-end spending deal, called the...
LRA Pleased to Share GSK’s Benlysta® (belimumab) is First Lupus Nephritis Treatment Approved by FDA Press Release NEW YORK, NY. December 17, 2020. The Lupus Research Alliance (LRA) congratulates GSK on the U.S. Food and Drug...
Over Half of People with Lupus Would Take COVID-19 Vaccine, Shows LRA Survey Press Release December 16, 2020 Updated January 4, 2021 New York, NY– December 16, 2020. More than half of people with lupus (54%) are willing...
Existing Cancer Drug May Lower Inflammation in Autoimmune Diseases Like Lupus News Update December 14, 2020 In a recent study published in the Journal of Immunology, LRA-funded researcher Dr. John Zhang at Medical...
New Survey Shows Education and Communication Gaps in Lupus Nephritis Care Press Release 1 in 2 Lupus Nephritis Patients Don’t Know They Have Lupus New York, NY– December 7, 2020. Significant gaps in...
LRA’s 2020 LMTA Grantees Focus on Finding Targets for New Lupus Drug Development Press Release NEW YORK, NY. December 3, 2020 - The Lupus Research Alliance is proud to announce the 2020 recipients of...
LRA-Supported Study Finds Similarities in the Immune Response Between Severe COVID-19 and Lupus Antiphospholipid Syndrome News Update December 2, 2020 The immune response during severe COVID-19 is similar to a lupus complication known as antiphospholipid syndrome, according...
Give the Lupus Community a Priceless Gift on Giving Tuesday News Update November 30, 2020 Every year, on December 1, the world shows its heartfelt support for the Lupus Research Alliance and...